New phase Ib/II trial evaluates pembrolizumab combination therapies in second-line ES-SCLC July 29, 2021
IDMC of phase II study of EscharEx for venous leg ulcers recommends continuation of trial July 29, 2021
Selinexor shows antiviral and the anti-inflammatory effects in models of SARS-CoV-2 infection July 29, 2021
ISIS-814907 well tolerated in first-in-human study in mild Alzheimer's disease patients July 29, 2021
FDA authorizes phase II study of autologous adipose-derived mesenchymal stem cells in MS July 29, 2021
RSS